Figure 2From: A systematic review of biomarkers for disease progression in Parkinson’s disease Flow diagram outlying a provisional ‘roadmap’ for conducting a study to determine whether a given biomarker is a suitable surrogate for a clinical measure of disease progression. Back to article page